PTQ Share Price | Quipt Home Medical Corp. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

40.0 k

Shareholding (Sep 2025)

FII

50.14%

Held by 164 FIIs

DII

48.72%

Held by 3 DIIs

Promoter

1.07%

Compare Quipt Home Medical Corp. with Similar Stocks

Akumin, Inc.CloudMD Software & Services, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared negative results for the last 8 consecutive quarters

The company has declared negative results in Mar 23 after 4 consecutive negative quarters
ROCE(HY) Lowest at -9.96%
INTEREST COVERAGE RATIO(Q) Lowest at 415.29
INVENTORY TURNOVER RATIO(HY) Lowest at 4.84%

Risky -

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

CAD 219 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.92

Return on Equity

-10.22%

Price to Book

1.57

Revenue and Profits:

Net Sales:

94 Million

(Quarterly Results - Sep 2025)

Net Profit:

-5 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

50.15%

6 Months

60.53%

1 Year

6.09%

2 Years

-22.17%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Quipt Home Medical Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Quipt Home Medical Corp. Hits Day High with 32.48% Surge

Quipt Home Medical Corp. has seen notable stock activity, rising significantly today and over the past week. However, the company has struggled financially, reporting negative results for eight consecutive quarters and facing operational inefficiencies. With a market cap of CAD 156 million, it operates in the miscellaneous industry.

Read full news article

Quipt Home Medical Corp. Hits Day High with 8.17% Surge

Quipt Home Medical Corp. saw a significant stock increase today, contrasting with the modest gain of the S&P/TSX 60. Despite recent positive trends, the company has struggled with negative results over the past eight quarters and has a low return on capital employed, alongside inventory management challenges.

Read full news article

Quipt Home Medical Corp. Hits Day High with 7.12% Surge

Quipt Home Medical Corp. saw a significant stock increase on November 7, 2025, reaching an intraday high of CAD 3.46. However, the company has struggled over the past year, with a market cap of CAD 159 million and ongoing operational challenges reflected in negative quarterly results.

Read full news article

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

28.53%

EBIT Growth (5y)

-209.99%

EBIT to Interest (avg)

0.31

Debt to EBITDA (avg)

1.19

Net Debt to Equity (avg)

0.67

Sales to Capital Employed (avg)

1.22

Tax Ratio

2.20%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

63.29%

ROCE (avg)

3.85%

ROE (avg)

3.70%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.09

EV to EBIT

-102.70

EV to EBITDA

4.10

EV to Capital Employed

1.05

EV to Sales

0.75

PEG Ratio

Dividend Yield

ROCE (Latest)

-1.03%

ROE (Latest)

-9.44%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 2 Schemes (0.07%)

Foreign Institutions

Held by 164 Foreign Institutions (50.14%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 12.43% vs -0.24% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -6.82% vs -144.44% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "94.10",
          "val2": "83.70",
          "chgp": "12.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.70",
          "val2": "15.20",
          "chgp": "-3.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "2.90",
          "chgp": "-20.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-1.50",
          "chgp": "46.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.70",
          "val2": "-4.40",
          "chgp": "-6.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-17.30%",
          "val2": "-6.90%",
          "chgp": "-1.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is 2.54% vs 17.20% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is -60.87% vs -142.11% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "343.10",
          "val2": "334.60",
          "chgp": "2.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.90",
          "val2": "65.50",
          "chgp": "-7.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.60",
          "val2": "12.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "-2.10",
          "chgp": "76.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-14.80",
          "val2": "-9.20",
          "chgp": "-60.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7.90%",
          "val2": "14.40%",
          "chgp": "-2.23%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

94.10

83.70

12.43%

Operating Profit (PBDIT) excl Other Income

14.70

15.20

-3.29%

Interest

2.30

2.90

-20.69%

Exceptional Items

-0.80

-1.50

46.67%

Consolidate Net Profit

-4.70

-4.40

-6.82%

Operating Profit Margin (Excl OI)

-17.30%

-6.90%

-1.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 12.43% vs -0.24% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -6.82% vs -144.44% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

343.10

334.60

2.54%

Operating Profit (PBDIT) excl Other Income

60.90

65.50

-7.02%

Interest

12.60

Exceptional Items

-0.50

-2.10

76.19%

Consolidate Net Profit

-14.80

-9.20

-60.87%

Operating Profit Margin (Excl OI)

-7.90%

14.40%

-2.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Sep 2025 is 2.54% vs 17.20% in Sep 2024

Consolidated Net Profit

YoY Growth in year ended Sep 2025 is -60.87% vs -142.11% in Sep 2024

All Annual Results

Company CV

About Quipt Home Medical Corp.

Quipt Home Medical Corp.

Miscellaneous

Protech Home Medical Corp., formerly Patient Home Monitoring Corp. is a healthcare service company. The Company is engaged in providing in-home monitoring equipment, supplies and services to patients in the United States. It operates through three segments: Viemed, PHM and Corporate. The Viemed segment is a Medicare durable medical equipment supplier that provides non-invasive ventilation equipment and services across the nation. The PHM segment provides in-home monitoring and disease management services for patients in the United States healthcare market. It offers services, such as respiratory disease management, including chronic obstructive pulmonary disease; equipment solutions; in-home sleep testing; sleep apnea and positive airway pressure treatment; oxygen therapy; respiratory equipment rental, and international normalized ratio (INR) self-testing. The Viemed segment has operations throughout the Central and Southern United States.

Company Coordinates

Company Details

1019 TOWN DRIVE , WILDER KY : 41076

Tel: 1 859 8782220

https://www.protechhomemedical.com/

Registrar Details